NeoGenomics subsidiary settles with former CEO Clive Morris for £607,500 in termination payments

NEOGENOMICS INC

Settlement includes £202,500 payment in lieu of notice, £303,750 retention cash bonus component, and £101,250 pro-rated MIP bonus.
Additional payment for accrued vacation and legal fees up to £2,000 plus VAT.
Dr. Morris served as CEO of Inivata Limited, a wholly owned NeoGenomics subsidiary; employment terminated June 30, 2022.
Agreement includes full release of claims, confidentiality, and non-disparagement obligations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.